(a) Specifications.
Sodium liothyronine tablets consist of tablets intended for oral administration which contain liothyronine at 60 or 120 micrograms per tablet, as the sodium salt.
(b) Sponsor.
See No. 000069 in § 510.600(c) of this chapter.
(c) Conditions of use.
(1)
It is indicated in cases of hypothyroidism in dogs.
(2)
It is administered orally to dogs at levels up to 12.8 micrograms per kilogram of body weight per day. Dosage should be adjusted according to the severity of the condition and the response of the patient. Dosage at the total replacement level (12.8µg per kilogram of body weight) should be considered for initiating therapy and then titrated downward for optimum maintenance effect. Twice daily administration is recommended.
(3)
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Code of Federal Regulations
[40 FR 13838, Mar. 27, 1975, as amended at 56 FR 50653, Oct. 8, 1991; 60 FR 55659, Nov. 2, 1995]